Facebook
Messenger
Twitter
LinkedIn
Email
Print
Mayo Researchers Explore Genetics Behind COVID-19 Outcomes
Share this:
Some patients with COVID-19 experience severe complications, such as organ damage, shortness of breath, neurological impairment and chronic fatigue. A team of researchers within Mayo Clinic Center for Individualized Medicine is contributing to the global effort of using advanced genetic sequencing to find out which genes influence disease outcomes.
“Our findings will be crucial in treating and caring for COVID-19 survivors, as well as to try to prevent lingering complications in newly infected people,” says Konstantinos Lazaridis, M.D., the Everett J. and Jane M. Hauck associate director of Mayo Clinic Center for Individualized Medicine.
Dr. Lazaridis and his team are building a library of genomic sequencing data of consented patients who tested positive for COVID-19. Learn more about Dr. Lazaridis' work at the Center for Individualized Medicine.
Make a gift now to help transform the future of health care today.
After a bleak diagnosis and many twists and turns for Chase Fairbairn and his family, hope came in the form of a lifesaving heart transplant at Mayo Clinic five years ago.
Thomas Grainger understands there is no end to medical discovery. That's why he and his wife Elizabeth put their trust in Mayo Clinic to find meaningful answers today – and far into the future.
Cheryl L. Willman, M.D., director of Mayo Clinic Cancer Center, discusses her early vision, engagement with communities and the vital role patients play in advancing cancer care for all.